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Background
Heparin induced thrombocytopenia type II (HIT type II) is
well defined thrombophylic and immunological complica-
tion due to heparin therapy, Witch occurs in 1-3% treated
patients. In around 50% of the patients with HIT type II
have developed serious thrombotic arterial and venous
complications. It has a special place in cardiac surgery,
regarding standard use of heparin. In patients with HIT
type II is contraindicated continuation of heparin therapy
including use of low molecular heparin. Alternative drugs
should be used as danaparoid sodium, lepirudin ,
argatroban.
Methods
Coronary revascularization was done in three patients and
mitral valve repair was done in one patient. First was male,
50 years old, who has suffered three myocardial infarctions
(MI) previously and has developed left ventricular low
ejection fraction of 25%. He had three vessels disease.
We performed revascularization off pump (one arterial
and one vein graft) using danaparoid sodium as alternative
anticoagulation. Second patient was male, 65 years old,
who previously suffered two MI and had three vessels
disease. We did a coronary revascularization on pump
(three vein grafts) using danaparoud sodium. Third coron-
ary patient was male, 46 years old with two previous MI
and three vessels disease. We performed revascularization
off pump (two arterial and one vein graft) using danapar-
oid sodium, as alternative anticoagulation.
Results
In all patients, during operation and postoperatively we
had no complications, except in second patient who had
superficial wound infection.
Conclusion
The diagnosis and treatment of HIT type II needs to be
considered on an individual basis, because of the variable
presentation and severity of the syndrome. Special atten-
tion should be placed on platelet count in patients who
received heparin therapy. In cardiac surgery, we need a
better screening test to discovery the HIT type II patients
who are previously treated with heparin.
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